Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Jun-23 5:31 PM View:  | Ironwood Pharmaceuticals Inc (IRWD) | 20-Jun-23 | Grant | 22,350 | -- | -- | 28% 79.89K to 102.24K | |
| 16-Jun-23 4:06 PM View: | Esperion Therapeutics, Inc. (ESPR) | 15-Jun-23 | Grant | 5,150 | -- | -- | 22% 23.45K to 28.6K | |
| 16-May-23 4:53 PM View: | Inovio Biomedical Corp. (INO) | 16-May-23 | Option Exercise | 19,000 | -- | -- | 48% 39.52K to 58.52K | |
| 17-Jan-23 4:05 PM View: | Inovio Biomedical Corp. (INO) | 15-Jan-23 | Option Exercise | 4,273 | -- | -- | 12% 35.25K to 39.52K | |
| 03-Jun-22 4:06 PM View: | Ironwood Pharmaceuticals Inc (IRWD) | 01-Jun-22 | Grant | 21,571 | -- | -- | 37% 58.32K to 79.89K | |
| 17-May-22 4:29 PM View: | Inovio Biomedical Corp. (INO) | 13-May-22 | Option Exercise | 18,000 | -- | -- | 104% 17.25K to 35.25K | |
| 18-Jan-22 4:06 PM View: | Inovio Biomedical Corp. (INO) | 15-Jan-22 | Option Exercise | 4,274 | -- | -- | 33% 12.97K to 17.25K | |
| 04-Jun-21 4:19 PM View: | Ironwood Pharmaceuticals Inc (IRWD) | 02-Jun-21 | Grant | 22,766 | -- | -- | 64% 35.56K to 58.32K | |
| 28-May-21 4:18 PM View: | Esperion Therapeutics, Inc. (ESPR) | 27-May-21 | Grant | 12,376 | -- | -- | 112% 11.07K to 23.45K | |
| 17-May-21 4:28 PM View: | Inovio Biomedical Corp. (INO) | 14-May-21 | Option Exercise | 8,700 | -- | -- | 204% 4.27K to 12.97K | |
| 15-Jan-21 7:24 PM View: | Inovio Biomedical Corp. (INO) | 15-Jan-21 | Option Exercise | 4,274 | -- | -- | 100% 0 to 4.27K | |
| 03-Dec-20 4:34 PM View: | Ironwood Pharmaceuticals Inc (IRWD) | 03-Dec-20 | Grant | 35,557 | -- | -- | 100% 0 to 35.56K | |
| 29-May-20 4:39 PM View: | Esperion Therapeutics, Inc. (ESPR) | 28-May-20 | Grant | 6,106 | -- | -- | 123% 4.97K to 11.07K | |
| 09-Apr-20 4:05 PM View: | Aravive, Inc. (ARAV) | 08-Apr-20 | Disposition | 9,291 | -- | -- | (13%) 70.49K to 61.2K | |
| 26-Dec-19 4:05 PM View: | Aravive, Inc. (ARAV) | 20-Dec-19 | Payment of Exercise | 2,262 | $11.67 | $26,397.50 | (3%) 72.75K to 70.49K | 47% |
| 08-Oct-19 4:08 PM View: | Aravive, Inc. (ARAV) | 07-Oct-19 | Market Sale | 4,004 | $6.82 | $27,295.30 | (5%) 76.76K to 72.75K | 9% |
| 31-May-19 4:50 PM View: | Esperion Therapeutics, Inc. (ESPR) | 29-May-19 | Grant | 4,967 | -- | -- | 100% 0 to 4.97K | |
| 13-May-19 6:15 PM View: | Aravive, Inc. (ARAV) | 10-May-19 | Market Sale | 1,192 | $6.11 | $7,283.12 | (2%) 77.95K to 76.76K | (2%) |
| 05-Feb-19 7:53 PM View: | Aravive, Inc. (ARAV) | 01-Feb-19 | Market Sale | 2,163 | $4.14 | $8,954.82 | (3%) 84.11K to 81.95K | (50%) |
| 26-Dec-18 8:01 PM View: | Aravive, Inc. (ARAV) | 21-Dec-18 | Market Sale | 3,484 | $3.22 | $11,232.40 | (4%) 87.6K to 84.11K | (93%) |
| 19-Dec-18 7:59 PM View: | Aravive, Inc. (ARAV) | 17-Dec-18 | Market Sale | 11,247 | $3.96 | $44,560.60 | (11%) 98.84K to 87.6K | (57%) |
| 23-May-18 5:42 PM View: | Aravive, Inc. (ARAV) | 22-May-18 | Market Sale | 9,232 | $1.50 | $13,848.00 | (2%) 602.3K to 593.07K | 31% |
| 12-Feb-18 5:25 PM View: | Aravive, Inc. (ARAV) | 08-Feb-18 | Market Sale | 14,446 | $1.80 | $26,002.80 | (2%) 616.74K to 602.3K | 41% |
| 22-Dec-17 5:07 PM View: | Aravive, Inc. (ARAV) | 20-Dec-17 | Grant | 223,000 | -- | -- | 57% 393.74K to 616.74K | |
| 10-Oct-17 8:15 PM View: | Aravive, Inc. (ARAV) | 06-Oct-17 | Grant | 189,000 | -- | -- | 92% 204.74K to 393.74K | |
| 15-May-17 10:00 PM View: | Aravive, Inc. (ARAV) | 11-May-17 | Market Sale | 9,114 | $17.50 | $159,495.00 | (4%) 213.86K to 204.74K | 94% |
| 28-Feb-17 10:00 PM View: | Aravive, Inc. (ARAV) | 27-Feb-17 | Option Exercise | 5,166 | $2.53 | $13,070.00 | 2% 213.86K to 219.02K | |
| 28-Feb-17 10:00 PM View: | Aravive, Inc. (ARAV) | 27-Feb-17 | Market Option Sale (Planned) | 5,166 | $24.00 | $123,984.00 | (2%) 219.02K to 213.86K | 95% |
| 23-Feb-17 8:23 PM View: | Aravive, Inc. (ARAV) | 23-Feb-17 | Option Exercise | 8,000 | $2.53 | $20,240.00 | 4% 213.86K to 221.86K | |
| 23-Feb-17 8:23 PM View: | Aravive, Inc. (ARAV) | 23-Feb-17 | Market Option Sale (Planned) | 8,000 | $20.00 | $160,000.00 | (4%) 221.86K to 213.86K | 95% |
| 23-Feb-17 8:23 PM View: | Aravive, Inc. (ARAV) | 21-Feb-17 | Option Exercise | 8,000 | $2.53 | $20,240.00 | 4% 213.86K to 221.86K | |
| 23-Feb-17 8:23 PM View: | Aravive, Inc. (ARAV) | 21-Feb-17 | Market Option Sale (Planned) | 8,000 | $18.50 | $148,000.00 | (4%) 221.86K to 213.86K | 94% |
| 06-Feb-17 5:23 PM View: | Aravive, Inc. (ARAV) | 03-Feb-17 | Market Sale (Planned) | 6,719 | $13.69 | $91,983.10 | (3%) 220.58K to 213.86K | 92% |
| 02-Feb-17 8:12 PM View: | Aravive, Inc. (ARAV) | 02-Feb-17 | Option Exercise | 4,166 | $2.53 | $10,540.00 | 2% 223.38K to 227.55K | |
| 02-Feb-17 8:12 PM View: | Aravive, Inc. (ARAV) | 02-Feb-17 | Market Option Sale (Planned) | 4,166 | $13.51 | $56,282.70 | (2%) 227.55K to 223.38K | 92% |
| 02-Feb-17 8:12 PM View: | Aravive, Inc. (ARAV) | 02-Feb-17 | Market Sale (Planned) | 2,807 | $13.51 | $37,922.60 | (1%) 223.38K to 220.58K | 92% |
| 02-Feb-17 8:12 PM View: | Aravive, Inc. (ARAV) | 01-Feb-17 | Option Exercise | 6,576 | $2.53 | $16,637.30 | 3% 223.38K to 229.96K | |
| 02-Feb-17 8:12 PM View: | Aravive, Inc. (ARAV) | 01-Feb-17 | Market Option Sale (Planned) | 6,576 | $13.95 | $91,735.20 | (3%) 229.96K to 223.38K | 92% |
| 02-Feb-17 8:12 PM View: | Aravive, Inc. (ARAV) | 31-Jan-17 | Option Exercise | 10,662 | $2.53 | $26,974.90 | 5% 223.38K to 234.05K | |
| 02-Feb-17 8:12 PM View: | Aravive, Inc. (ARAV) | 31-Jan-17 | Market Option Sale (Planned) | 10,662 | $13.82 | $147,385.00 | (5%) 234.05K to 223.38K | 92% |
| 31-Jan-17 8:34 PM View: | Aravive, Inc. (ARAV) | 30-Jan-17 | Option Exercise | 10,596 | $2.53 | $26,807.90 | 5% 230.06K to 240.65K | |
| 31-Jan-17 8:34 PM View: | Aravive, Inc. (ARAV) | 30-Jan-17 | Market Option Sale | 6,674 | $13.85 | $92,434.90 | (3%) 240.65K to 233.98K | 92% |
| 31-Jan-17 8:34 PM View: | Aravive, Inc. (ARAV) | 30-Jan-17 | Market Option Sale (Planned) | 3,922 | $13.31 | $52,201.80 | (2%) 233.98K to 230.06K | 92% |
| 31-Jan-17 8:34 PM View: | Aravive, Inc. (ARAV) | 30-Jan-17 | Market Sale (Planned) | 6,674 | $13.31 | $88,830.90 | (3%) 230.06K to 223.38K | 92% |
| 31-Jan-17 8:34 PM View: | Aravive, Inc. (ARAV) | 27-Jan-17 | Grant | 74,700 | -- | -- | 48% 155.36K to 230.06K | |
| 24-Aug-16 6:22 PM View: | Aravive, Inc. (ARAV) | 22-Aug-16 | Market Sale | 5,442 | $12.88 | $70,093.00 | (3%) 160.8K to 155.36K | 92% |
| 01-Feb-16 7:16 PM View: | Aravive, Inc. (ARAV) | 28-Jan-16 | Grant | 64,800 | -- | -- | 68% 96.0K to 160.8K | |
| 13-May-15 5:07 PM View: | Aravive, Inc. (ARAV) | 11-May-15 | Grant | 96,000 | -- | -- | 100% 0 to 96.0K |